PACS Group is trading 4.02% down now at $46.50; no clear company-specific announcement, filing, analyst action or other catalyst explaining the decline was identified in available coverage, despite the healthcare sector gaining 1.26% on August 11, 2026.
- Latest results, released August 4, showed second-quarter revenue of $1.43 billion.
- The company raised 2026 guidance, making those results unlikely to explain today’s weakness.